Join Federation’s Greater MetroWest ABLE and Business & Professionals Network (BPN) to gain insights and strategies to enhance your workforce with an untapped part of our community, people with disabilities. We’ll hear from with industry...
This course will discuss how conducting ecological evaluations have evolved not only through regulatory and guidance updates, but also with emerging contaminants that must now be evaluated and considered, despite limited toxicological data. This c...
On March 19, the Securities and Exchange Commission (SEC) issued a new FAQ response1 that softens prior guidance on the use of gross and net performance in advertisements. The new FAQs (the New Guidance) reduce the burden of certain positions adva...
Lowenstein Sandler represented Relmada Therapeutics, Inc. in an exclusive licensing agreement with Trigone Pharma, Ltd. for NDV-01, a clinical stage product candidate for the treatment of non-muscle invasive bladder cancer (NMIBC). NDV-01 is curr...
As discussed in our March 4 Client Alert, following its February 27 and March 2 announcements suspending enforcement of the Corporate Transparency Act (CTA) and promising additional CTA compliance guidance, on the evening of March 21, the Departme...